Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer
Links shared publicly online about this topic.
- 217total visits
Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that nearly half of surveyed urologists view the approval of Dendreon's P
View full resource at medicalnewstoday.com
Tags: Prostate Cancer, Prostate Cancer Medication, Prostate, Men's Health, Provenge, Urologist, Urology
Most Recently Shared on June 15, 2011 at 3:07 pm By:
Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer http://mnt.to/3XdM
Also Shared By:
Advertisement
MNT Urology
@mnt_urology
Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer http://mnt.to/3XdM
1 year ago...